Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1.076,13
-15,38
-1,41%
—1.091,511.090,401.090,401.073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1.248,82
+10,84
+0,88%
—1.237,981.237,831.252,411.225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1.724,36
-20,35
-1,17%
—1.744,711.740,951.747,291.721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3.263,41
+2,72
+0,08%
—3.260,693.273,363.287,813.240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1.462,56
-4,24
-0,29%
—1.466,801.464,701.467,191.458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2.380,40
-17,10
-0,71%
—2.397,502.395,032.412,012.370,64——
GRF:BME
Grifols SA Class A
€9,11
+1,63%
(+0,15) 1D
4 ພ.ພ., 17 ໂມງ 36 ນາທີ 00 ວິນາທີ GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GRF...
Open
€9,05
High
€9,15
Low
€8,88
Mkt. cap
໕,໗໖ ຕື້
Avg. vol.
໒,໖໔ ລ້ານ
Volume
໑,໗໒ ລ້ານ
Dividend
໑,໖໕%
Quarterly dividend
€0,04
Ex dividend date
11 ສ.ຫ. 2025
P/E ratio
໑໕,໔໑
52-wk high
€13,70
52-wk low
€8,01
EPS
€0,59
Shares outstanding
໔໒໖,໑໓ ລ້ານ
No. of employees
໒໕ ພັນ
News stories
From sources across the web
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30. Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A
CEONacho Abia
Employees25,3 ພັນ
Founded18 ພ.ຈ. 1940
Headquarters-
SectorBiotechnology
Websitegrifols.com
Last report
26 ກ.ພ. 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
-/ -EUR
Revenue / Estimate
໑,໙໘ ຕື້/ (໑,໙໖ ຕື້ est.)EUR
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
ມ.ນ. 2025
ມິ.ຖ. 2025
ກ.ຍ. 2025
ທ.ວ. 2025
Revenue
1,79 ຕື້
1,89 ຕື້
1,87 ຕື້
1,98 ຕື້
Cost of goods sold
1,08 ຕື້
1,15 ຕື້
1,11 ຕື້
1,28 ຕື້
Cost of revenue
1,08 ຕື້
1,15 ຕື້
1,11 ຕື້
1,28 ຕື້
Research and development expenses
96,05 ລ້ານ
96,19 ລ້ານ
97,01 ລ້ານ
90,82 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
315,37 ລ້ານ
298,06 ລ້ານ
273,76 ລ້ານ
262,86 ລ້ານ
Operating expense
411,42 ລ້ານ
394,25 ລ້ານ
370,34 ລ້ານ
353,11 ລ້ານ
Total operating expenses
1,49 ຕື້
1,54 ຕື້
1,48 ຕື້
1,63 ຕື້
Operating income
293,22 ລ້ານ
349,54 ລ້ານ
381,18 ລ້ານ
347,38 ລ້ານ
Other non operating income
-
8,08 ລ້ານ
-
-33,00 ລ້ານ
EBT including unusual items
115,26 ລ້ານ
190,51 ລ້ານ
198,13 ລ້ານ
111,10 ລ້ານ
EBT excluding unusual items
134,52 ລ້ານ
190,51 ລ້ານ
227,20 ລ້ານ
183,10 ລ້ານ
Income tax expense
22,84 ລ້ານ
52,13 ລ້ານ
54,71 ລ້ານ
-14,68 ລ້ານ
Effective tax rate
19,82%
27,36%
27,61%
-13,21%
Other operating expenses
-
-
-430,00 ພັນ
-570,00 ພັນ
Net income
59,72 ລ້ານ
117,06 ລ້ານ
126,96 ລ້ານ
98,25 ລ້ານ
Net profit margin
3,34%
6,19%
6,81%
4,96%
Earnings per share
-
0,19
-
-
Interest and investment income
-
9,56 ລ້ານ
-
36,00 ລ້ານ
Interest expense
-153,59 ລ້ານ
-141,43 ລ້ານ
-156,07 ລ້ານ
-107,99 ລ້ານ
Net interest expenses
-153,59 ລ້ານ
-131,88 ລ້ານ
-156,07 ລ້ານ
-71,99 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
404,97 ລ້ານ
414,24 ລ້ານ
484,03 ລ້ານ
422,88 ລ້ານ
Gain or loss from assets sale
-
732,00 ພັນ
-
2,00 ລ້ານ
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer